Abstract:OBJECTIVE In the development of diabetic retinopathy, mitochondrial dysfunction is considered to play an important role in the apoptosis of retinal capillary cells. Diabetes activates matrix metalloproteinase-9 (MMP-9) in the retina and its capillary cells, and activated MMP-9 becomes proapoptotic. The objective of this study is to elucidate the plausible mechanism by which active MMP-9 contributes to the mitochondrial dysfunction in the retina. RESEARCH DESIGN AND METHODS Using MMP-9 gene knockout (MMP-KO) mice, we investigated the effect of MMP-9 regulation on diabetes-induced increased retinal capillary cell apoptosis, development of retinopathy, mitochondrial dysfunction and ultrastructure, and mitochondrial DNA (mtDNA) damage. To understand how diabetes increases mitochondrial accumulation of MMP-9, interactions between MMP-9 and chaperone proteins (heat shock protein [Hsp] 70 and Hsp60) were evaluated. The results were confirmed in the retinal mitochondria from human donors with diabetic retinopathy, and in isolated retinal endothelial cells transfected with MMP-9 small interfering RNA (siRNA). RESULTS Retinal microvasculature of MMP-KO mice, diabetic for ∼7 months, did not show increased apoptosis and pathology characteristic of retinopathy. In the same MMP-KO diabetic mice, activation of MMP-9 and dysfunction of the mitochondria were prevented, and electron microscopy of the retinal microvasculature region revealed normal mitochondrial matrix and packed lamellar cristae. Damage to mtDNA was protected, and the binding of MMP-9 with Hsp70 or Hsp60 was also normal. As in the retina from wild-type diabetic mice, activation of mitochondrial MMP-9 and alterations in the binding of MMP-9 with chaperone proteins were also observed in the retina from donors with diabetic retinopathy. In endothelial cells transfected with MMP-9 siRNA, high glucose–induced damage to the mitochondria and the chaperone machinery was ameliorated. CONCLUSIONS Regulation of activated MMP-9 prevents retinal capillary cells from undergoing apoptosis by protecting mitochondrial ultrastructure and function and preventing mtDNA damage. Thus, MMP-9 inhibitors could have potential therapeutic value in preventing the development of diabetic retinopathy by preventing the continuation of the vicious cycle of mitochondrial damage.

Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.

Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy

Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy

Sirt1, a Negative Regulator of Matrix Metalloproteinase-9 in Diabetic Retinopathy

Abrogation of Mmp-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage

Matrix Metalloproteinases in Diabetic Retinopathy: Potential Role of MMP-9

Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation

Regulation of Rac1 transcription by histone and DNA methylation in diabetic retinopathy

Epigenetic Modification Ofsod2in the Development of Diabetic Retinopathy and in the Metabolic Memory: Role of Histone Methylation

Epigenetic Modifications of Nrf2-mediated Glutamate–cysteine Ligase: Implications for the Development of Diabetic Retinopathy and the Metabolic Memory Phenomenon Associated with Its Continued Progression

Epigenetic Changes in Mitochondrial Superoxide Dismutase in the Retina and the Development of Diabetic Retinopathy.

Epigenetic Modifications of Keap1 Regulate Its Interaction with the Protective Factor Nrf2 in the Development of Diabetic Retinopathy

Role of Histone Acetylation in the Development of Diabetic Retinopathy and the Metabolic Memory Phenomenon

GADD45a Promotes Active DNA Demethylation of the MMP-9 Promoter Via Base Excision Repair Pathway in AGEs-Treated Keratinocytes and in Diabetic Male Rat Skin

Role of MMP-9 and NF-κB in Diabetic Retinopathy: Progression and Potential Role of Bioflavonoids in the Mitigation of Diabetic Retinopathy

Regulation of serine palmitoyl-transferase and Rac1–Nox2 signaling in diabetic retinopathy

AGE-induced keratinocyte MMP-9 expression is linked to TET2-mediated CpG demethylation.

Mitochondrial DNA transcription and mitochondrial genome-encoded long noncoding RNA in diabetic retinopathy

Deacetylation of MnSOD by PARP-regulated SIRT3 Protects Retinal Capillary Endothelial Cells from Hyperglycemia-Induced Damage

A glimpse of matrix metalloproteinases in diabetic nephropathy.

Kdm6a Deficiency in Microglia/macrophages Epigenetically Silences Lcn2 Expression and Reduces Photoreceptor Dysfunction in Diabetic Retinopathy.